{"id":"https://openalex.org/W3164774422","doi":"https://doi.org/10.1021/acs.jmedchem.1c00903","title":"DoE Optimization Empowers the Automated Preparation of Enantiomerically Pure [ 18 F]Talazoparib and its In Vivo Evaluation as a PARP Radiotracer","display_name":"DoE Optimization Empowers the Automated Preparation of Enantiomerically Pure [ 18 F]Talazoparib and its In Vivo Evaluation as a PARP Radiotracer","publication_year":2021,"publication_date":"2021-10-21","ids":{"openalex":"https://openalex.org/W3164774422","doi":"https://doi.org/10.1021/acs.jmedchem.1c00903","mag":"3164774422","pmid":"https://pubmed.ncbi.nlm.nih.gov/34672571"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.1c00903","doi":"https://doi.org/10.1021/acs.jmedchem.1c00903","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.1c00903","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.26434/chemrxiv.14587401","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051813573","display_name":"Gregory D. Bowden","orcid":"https://orcid.org/0000-0003-2274-6738","observed_orcids":["https://orcid.org/0000-0003-2274-6738"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gregory D. Bowden","raw_affiliation_strings":["Cluster of Excellence iFIT (EXC 2180) \u201cImage-Guided and Functionally Instructed Tumor Therapies\u201d, Eberhard Karls University, Roentgenweg 13, 72076 Tuebingen, Germany","Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Roentgenweg 15, 72076 Tuebingen, Germany"],"raw_orcid":"https://orcid.org/0000-0003-2274-6738","affiliations":[{"raw_affiliation_string":"Cluster of Excellence iFIT (EXC 2180) \u201cImage-Guided and Functionally Instructed Tumor Therapies\u201d, Eberhard Karls University, Roentgenweg 13, 72076 Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]},{"raw_affiliation_string":"Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Roentgenweg 15, 72076 Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079754982","display_name":"Sophie Stotz","orcid":"https://orcid.org/0000-0003-4020-1088","observed_orcids":["https://orcid.org/0000-0003-4020-1088"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sophie Stotz","raw_affiliation_strings":["Cluster of Excellence iFIT (EXC 2180) \u201cImage-Guided and Functionally Instructed Tumor Therapies\u201d, Eberhard Karls University, Roentgenweg 13, 72076 Tuebingen, Germany","Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Roentgenweg 15, 72076 Tuebingen, Germany"],"raw_orcid":"https://orcid.org/0000-0003-4020-1088","affiliations":[{"raw_affiliation_string":"Cluster of Excellence iFIT (EXC 2180) \u201cImage-Guided and Functionally Instructed Tumor Therapies\u201d, Eberhard Karls University, Roentgenweg 13, 72076 Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]},{"raw_affiliation_string":"Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Roentgenweg 15, 72076 Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078626180","display_name":"Johannes Kinzler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Johannes Kinzler","raw_affiliation_strings":["Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Roentgenweg 15, 72076 Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Roentgenweg 15, 72076 Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071190198","display_name":"Christian Geibel","orcid":"https://orcid.org/0009-0002-2044-9422","observed_orcids":["https://orcid.org/0009-0002-2044-9422"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christian Geibel","raw_affiliation_strings":["Institute of Pharmaceutical Sciences, Department of Pharmaceutical (Bio-)Analysis, Eberhard Karls University, Auf der Morgenstelle 8, 72076 Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmaceutical Sciences, Department of Pharmaceutical (Bio-)Analysis, Eberhard Karls University, Auf der Morgenstelle 8, 72076 Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111771080","display_name":"Michael L\u00e4mmerhofer","orcid":"https://orcid.org/0000-0002-1318-0974","observed_orcids":["https://orcid.org/0000-0002-1318-0974"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael L\u00e4mmerhofer","raw_affiliation_strings":["Institute of Pharmaceutical Sciences, Department of Pharmaceutical (Bio-)Analysis, Eberhard Karls University, Auf der Morgenstelle 8, 72076 Tuebingen, Germany"],"raw_orcid":"https://orcid.org/0000-0002-1318-0974","affiliations":[{"raw_affiliation_string":"Institute of Pharmaceutical Sciences, Department of Pharmaceutical (Bio-)Analysis, Eberhard Karls University, Auf der Morgenstelle 8, 72076 Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018788118","display_name":"Bernd J\u00fcrgen Pichler","orcid":"https://orcid.org/0000-0001-6784-5524","observed_orcids":["https://orcid.org/0000-0001-6784-5524"]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]},{"id":"https://openalex.org/I4391767962","display_name":"Deutsches Konsortium f\u00fcr Translationale Krebsforschung","ror":"https://ror.org/02pqn3g31","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4391767962","https://openalex.org/I4405256427"]},{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Bernd J. Pichler","raw_affiliation_strings":["Cluster of Excellence iFIT (EXC 2180) \u201cImage-Guided and Functionally Instructed Tumor Therapies\u201d, Eberhard Karls University, Roentgenweg 13, 72076 Tuebingen, Germany","German Cancer Research Center, German Cancer Consortium DKTK, Partner Site Tuebingen, Roentgenweg 13, 72076 Tuebingen, Germany","Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Roentgenweg 15, 72076 Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cluster of Excellence iFIT (EXC 2180) \u201cImage-Guided and Functionally Instructed Tumor Therapies\u201d, Eberhard Karls University, Roentgenweg 13, 72076 Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]},{"raw_affiliation_string":"German Cancer Research Center, German Cancer Consortium DKTK, Partner Site Tuebingen, Roentgenweg 13, 72076 Tuebingen, Germany","institution_ids":["https://openalex.org/I17937529","https://openalex.org/I4391767962"]},{"raw_affiliation_string":"Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Roentgenweg 15, 72076 Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020683761","display_name":"Andreas Maurer","orcid":"https://orcid.org/0000-0003-2412-5361","observed_orcids":["https://orcid.org/0000-0003-2412-5361"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Andreas Maurer","raw_affiliation_strings":["Cluster of Excellence iFIT (EXC 2180) \u201cImage-Guided and Functionally Instructed Tumor Therapies\u201d, Eberhard Karls University, Roentgenweg 13, 72076 Tuebingen, Germany","Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Roentgenweg 15, 72076 Tuebingen, Germany"],"raw_orcid":"https://orcid.org/0000-0003-2412-5361","affiliations":[{"raw_affiliation_string":"Cluster of Excellence iFIT (EXC 2180) \u201cImage-Guided and Functionally Instructed Tumor Therapies\u201d, Eberhard Karls University, Roentgenweg 13, 72076 Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]},{"raw_affiliation_string":"Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University, Roentgenweg 15, 72076 Tuebingen, Germany","institution_ids":["https://openalex.org/I8087733"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5020683761"],"corresponding_institution_ids":["https://openalex.org/I8087733"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":2.5878,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.90542102,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"64","issue":"21","first_page":"15690","last_page":"15701"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13561","display_name":"Chemical Reactions and Isotopes","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/talazoparib","display_name":"talazoparib","score":0.8379999995231628},{"id":"https://openalex.org/keywords/automated-radiosynthesis","display_name":"automated radiosynthesis","score":0.7879999876022339},{"id":"https://openalex.org/keywords/design-of-experiments-optimization","display_name":"design of experiments optimization","score":0.8109999895095825},{"id":"https://openalex.org/keywords/copper-mediated-radiofluorination","display_name":"copper-mediated radiofluorination","score":0.9829999804496765},{"id":"https://openalex.org/keywords/tumor-to-blood-ratio","display_name":"tumor-to-blood ratio","score":0.8880000114440918},{"id":"https://openalex.org/keywords/tumor-imaging","display_name":"tumor imaging","score":0.4099999964237213}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.726820170879364},{"id":"https://openalex.org/C2776970183","wikidata":"https://www.wikidata.org/wiki/Q20155580","display_name":"Radiosynthesis","level":3,"score":0.6779978275299072},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.6437007188796997},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5926458835601807},{"id":"https://openalex.org/C3017724952","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Pet imaging","level":3,"score":0.5632688999176025},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.5372573733329773},{"id":"https://openalex.org/C2779301178","wikidata":"https://www.wikidata.org/wiki/Q3149007","display_name":"Imidazopyridine","level":2,"score":0.436614990234375},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4298168420791626},{"id":"https://openalex.org/C2778172261","wikidata":"https://www.wikidata.org/wiki/Q3796563","display_name":"Imaging agent","level":3,"score":0.411593496799469},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.39842426776885986},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38265544176101685},{"id":"https://openalex.org/C177322064","wikidata":"https://www.wikidata.org/wiki/Q750955","display_name":"Radiochemistry","level":1,"score":0.36174824833869934},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.2532578110694885},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.2521519660949707},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22511154413223267},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.19190910458564758},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.18174800276756287},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.08583599328994751},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001331","descriptor_name":"Automation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005462","descriptor_name":"Fluorine Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011065","descriptor_name":"Poly(ADP-ribose) Polymerases","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D011065","descriptor_name":"Poly(ADP-ribose) Polymerases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016688","descriptor_name":"Mice, Inbred NOD","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1021/acs.jmedchem.1c00903","doi":"https://doi.org/10.1021/acs.jmedchem.1c00903","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.1c00903","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"doi:10.26434/chemrxiv.14587401","doi":"https://doi.org/10.26434/chemrxiv.14587401","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.14587401","pdf_url":null,"source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"doi:10.26434/chemrxiv.14587401.v1","doi":"https://doi.org/10.26434/chemrxiv.14587401.v1","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.14587401.v1","pdf_url":"https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c758b7bdbb897071a3ae01/original/do-e-optimization-empowers-the-automated-preparation-of-enantiomerically-pure-18f-talazoparib-and-its-in-vivo-evaluation-as-a-parp-radiotracer.pdf","source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmid:34672571","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34672571","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/14587401","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/preprint/DoE_Optimization_Empowers_the_Automated_Preparation_of_Enantiomerically_Pure_18F_Talazoparib_and_its_In_Vivo_Evaluation_as_a_PARP_Radiotracer_/14587401","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.26434/chemrxiv.14587401","doi":"https://doi.org/10.26434/chemrxiv.14587401","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.14587401","pdf_url":null,"source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G2532469498","display_name":null,"funder_award_id":"EXC2180","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G2853181762","display_name":null,"funder_award_id":"EXC 2180\u2014390\u2009900\u2009677","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G932901508","display_name":"EXC 2180: Individualisierung von Tumortherapien durch molekulare Bildgebung und funktionelle Identifizierung therapeutischer Zielstrukturen (iFIT)","funder_award_id":"390900677","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"}],"funders":[{"id":"https://openalex.org/F4320317012","display_name":"Werner Siemens-Stiftung","ror":"https://ror.org/00qxcft19"},{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3164774422.pdf","grobid_xml":"https://content.openalex.org/works/W3164774422.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W1569090034","https://openalex.org/W1575178924","https://openalex.org/W1599703185","https://openalex.org/W1973268287","https://openalex.org/W2009007206","https://openalex.org/W2011476357","https://openalex.org/W2014060472","https://openalex.org/W2073660843","https://openalex.org/W2086038769","https://openalex.org/W2097722567","https://openalex.org/W2124092811","https://openalex.org/W2126928241","https://openalex.org/W2135409663","https://openalex.org/W2147154862","https://openalex.org/W2165040547","https://openalex.org/W2165058466","https://openalex.org/W2243234890","https://openalex.org/W2290133339","https://openalex.org/W2338647065","https://openalex.org/W2431934307","https://openalex.org/W2531782817","https://openalex.org/W2539944286","https://openalex.org/W2549834459","https://openalex.org/W2562508360","https://openalex.org/W2597062310","https://openalex.org/W2611270172","https://openalex.org/W2611848593","https://openalex.org/W2618384999","https://openalex.org/W2688973277","https://openalex.org/W2783441257","https://openalex.org/W2791794911","https://openalex.org/W2807452056","https://openalex.org/W2898838695","https://openalex.org/W2901174457","https://openalex.org/W2901569771","https://openalex.org/W2902946687","https://openalex.org/W2905294157","https://openalex.org/W2908112515","https://openalex.org/W2947586730","https://openalex.org/W2965637341","https://openalex.org/W2989981864","https://openalex.org/W3007949777","https://openalex.org/W3012328527","https://openalex.org/W3013911035","https://openalex.org/W3014754175","https://openalex.org/W3023296206","https://openalex.org/W3031828245","https://openalex.org/W3117358516","https://openalex.org/W3117735666","https://openalex.org/W3162286778","https://openalex.org/W3192921915","https://openalex.org/W4250724395"],"related_works":["https://openalex.org/W4233874651","https://openalex.org/W3162286778","https://openalex.org/W3192921915","https://openalex.org/W3007949777","https://openalex.org/W7171377731","https://openalex.org/W4282945864","https://openalex.org/W7163871861","https://openalex.org/W1983383818","https://openalex.org/W4281258189","https://openalex.org/W4281262776"],"abstract_inverted_index":{"Given":[0],"the":[1,10,17,46,84,145,156],"clinical":[2],"potential":[3],"of":[4,14,19,55,71,126,136,147,152],"poly(ADP-ribose)":[5],"polymerases":[6],"(PARP)":[7],"imaging":[8,22,31,157],"for":[9],"detection":[11],"and":[12,107,129],"stratification":[13],"various":[15],"cancers,":[16],"development":[18],"novel":[20,39],"PARP":[21,30,42,49,100],"probes":[23],"with":[24],"improved":[25],"pharmacological":[26,122],"profiles":[27],"over":[28],"established":[29],"agents":[32],"is":[33],"warranted.":[34],"Here,":[35],"we":[36],"present":[37],"a":[38,69,120],"18":[40,57,97,138],"F-labeled":[41],"radiotracer":[43],"based":[44],"on":[45],"clinically":[47],"superior":[48],"inhibitor":[50],"talazoparib.":[51],"An":[52],"automated":[53],"radiosynthesis":[54],"[":[56,137],"F]talazoparib":[58,139],"(RCY:":[59],"13":[60],"\u00b1":[61,117],"3.4%;":[62],"n":[63],"=":[64],"4)":[65],"was":[66,81,132],"achieved":[67],"using":[68,87],"\u201cdesign":[70],"experiments\u201d":[72],"(DoE)":[73],"optimized":[74],"copper-mediated":[75],"radiofluorination":[76],"reaction.":[77],"The":[78],"chiral":[79],"product":[80],"isolated":[82],"from":[83],"reaction":[85],"mixture":[86],"2D":[88],"reversed-phase/chiral":[89],"radio-HPLC":[90],"(>99%":[91],"ee).":[92],"(8":[93],"S,9":[94],"R":[95],")-[":[96],"F]Talazoparib":[98],"demonstrated":[99],"binding":[101],"in":[102,105,113,124],"HCC1937":[103],"cells":[104],"vitro":[106],"showed":[108],"an":[109],"excellent":[110],"tumor-to-blood":[111],"ratio":[112],"xenograft-bearing":[114],"mice":[115],"(10.2":[116],"1.5).":[118],"Additionally,":[119],"favorable":[121],"profile":[123],"terms":[125],"excretion,":[127],"metabolism,":[128],"target":[130],"engagement":[131],"observed.":[133],"This":[134],"synthesis":[135],"exemplifies":[140],"how":[141],"DoE":[142],"can":[143],"enable":[144],"radiosyntheses":[146],"synthetically":[148],"challenging":[149],"radiolabeled":[150],"compounds":[151],"high":[153],"interest":[154],"to":[155],"community.":[158]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-06-07T00:00:00"}